Compare ZLAB & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | ENVX |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2017 | N/A |
| Metric | ZLAB | ENVX |
|---|---|---|
| Price | $18.67 | $8.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $57.22 | $17.14 |
| AVG Volume (30 Days) | 810.7K | ★ 6.2M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $441,629,000.00 | $30,273,000.00 |
| Revenue This Year | $30.20 | $36.91 |
| Revenue Next Year | $34.71 | $117.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 24.14 | ★ 45.98 |
| 52 Week Low | $18.61 | $5.27 |
| 52 Week High | $44.34 | $16.49 |
| Indicator | ZLAB | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 21.76 | 51.73 |
| Support Level | $19.40 | $7.27 |
| Resistance Level | $20.22 | $9.17 |
| Average True Range (ATR) | 0.53 | 0.54 |
| MACD | 0.20 | 0.28 |
| Stochastic Oscillator | 5.02 | 92.17 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.